Timing of Enoxaparin Initiation After EVL in Patients with Active Variceal Bleeding
Immediate Post-EVL Period: Absolute Contraindication to Anticoagulation
- EVL inherently creates shallow ulcers at ligation sites that occur in approximately 14% of cases, making the immediate post-procedure period high-risk for bleeding 1
- Active variceal bleeding requires immediate vasoactive therapy (e.g. terlipressin, octreotide, or somatostatin) continued for 3-5 days after EVL, during which anticoagulation would be dangerous 2, 3
Evidence-Based Timing Algorithm
- Continue vasoactive agents for 3-5 days post-EVL as recommended by the Korean Association for the Study of the Liver 2
- Maintain prophylactic antibiotics (e.g. ceftriaxone 1g IV daily for up to 7 days) to reduce mortality and infection risk 2, 4
- Absolutely avoid any anticoagulation during this period - the combination of post-EVL ulcers and active bleeding risk makes enoxaparin contraindicated 1
Critical Safety Considerations
- Any evidence of ongoing or recent bleeding (within 48-72 hours) is an absolute contraindication to enoxaparin use 4
- Platelet count <50,000/μL is a contraindication to enoxaparin use in cirrhotic patients 5
- INR >2.0 despite vitamin K administration is a contraindication to enoxaparin use 5
- Consider proton pump inhibitor therapy (e.g. pantoprazole 40mg IV then oral daily) to reduce post-EVL ulcer size and bleeding risk 1